犬の関節炎治療の世界市場2019-2029

LINEで送る

1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

4. Market Context

4.1. Global Healthcare Market Outlook

4.2. Global Canine Arthritis Treatment Scenario

4.3. Pet Ownership in European Union (EU)

4.4. Share of Household Owing at least one Dog in European Union (EU)

4.5. Spending on Health of Pets

4.6. Vet care Spending on Dogs

4.7. Key Regulations and Guidelines

5. Global Canine Arthritis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

6. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 – 2029

6.3.1. Non-steroidal anti-inflammatory Medications (NSAIDs)

6.3.2. Opioids

6.3.3. Stem Cell Therapy

6.3.3.1. Allogeneic Stem Cells

6.3.3.2. Autologous Stem Cells

6.4. Market Attractiveness Analysis By Treatment Type

7. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2019 – 2029

7.3.1. Oral

7.3.2. Injectable

7.4. Market Attractiveness Analysis By Route of Administration

8. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

8.3.1. Veterinary Hospital and Clinics

8.3.2. Retail Pharmacies

8.3.3. Drug Stores

8.3.4. E-Commerce

8.3.5. Market Attractiveness Analysis By Distribution Channel

9. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia-Pacific Excluding Japan

9.3.5. Japan

9.3.6. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Treatment Type

10.3.3. By Route of Administration

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Treatment Type

10.4.3. By Route of Administration

10.4.4. By Distribution Channel

11. Latin America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. Mexico

11.3.1.2. Brazil

11.3.1.3. Rest of Latin America

11.3.2. By Treatment Type

11.3.3. By Route of Administration

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Treatment Type

11.4.3. By Route of Administration

11.4.4. By Distribution Channel

12. Europe Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. Russia

12.3.1.7. Rest of Europe

12.3.2. By Treatment Type

12.3.3. By Route of Administration

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Treatment Type

12.4.3. By Route of Administration

12.4.4. By Distribution Channel

13. APEJ Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia & New Zealand

13.3.1.4. ASEAN

13.3.1.5. Rest of APEJ

13.3.2. By Treatment Type

13.3.3. By Route of Administration

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Treatment Type

13.4.3. By Route of Administration

13.4.4. By Distribution Channel

14. Japan Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Treatment Type

14.3.2. By Route of Administration

14.3.3. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Treatment Type

14.4.2. By Route of Administration

14.4.3. By Distribution Channel

15. Middle East and Africa Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. Rest of MEA

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Treatment Type

15.4.3. By Route of Administration

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Deep Dive

16.2.1. Elanco (Eli Lily and Company)

16.2.1.1. Overview

16.2.1.2. Product Portfolio

16.2.1.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.1.4. Sales Footprint

16.2.1.5. Strategy Overview

16.2.1.5.1. Marketing Strategy

16.2.1.5.2. Product Strategy

16.2.1.5.3. Route of Administration Strategy

16.2.2. Ceva Santé Animale

16.2.2.1. Overview

16.2.2.2. Product Portfolio

16.2.2.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.2.4. Sales Footprint

16.2.2.5. Strategy Overview

16.2.2.5.1. Marketing Strategy

16.2.2.5.2. Product Strategy

16.2.2.5.3. Route of Administration Strategy

16.2.3. Vetoquinol S.A

16.2.3.1. Overview

16.2.3.2. Product Portfolio

16.2.3.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.3.4. Sales Footprint

16.2.3.5. Strategy Overview

16.2.3.5.1. Marketing Strategy

16.2.3.5.2. Product Strategy

16.2.3.5.3. Route of Administration Strategy

16.2.4. Norbrook Laboratories Limited

16.2.4.1. Overview

16.2.4.2. Product Portfolio

16.2.4.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.4.4. Sales Footprint

16.2.4.5. Strategy Overview

16.2.4.5.1. Marketing Strategy

16.2.4.5.2. Product Strategy

16.2.4.5.3. Route of Administration Strategy

16.2.5. Aratana Therapeutics IncMylan Pharmaceuticals Inc.

16.2.5.1. Overview

16.2.5.2. Product Portfolio

16.2.5.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.5.4. Sales Footprint

16.2.5.5. Strategy Overview

16.2.5.5.1. Marketing Strategy

16.2.5.5.2. Product Strategy

16.2.5.5.3. Route of Administration Strategy

16.2.6. Boehringer Ingelheim

16.2.6.1. Overview

16.2.6.2. Product Portfolio

16.2.6.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.6.4. Sales Footprint

16.2.6.5. Strategy Overview

16.2.6.5.1. Marketing Strategy

16.2.6.5.2. Product Strategy

16.2.6.5.3. Route of Administration Strategy

16.2.7. Zoetis Inc

16.2.7.1. Overview

16.2.7.2. Product Portfolio

16.2.7.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.7.4. Sales Footprint

16.2.7.5. Strategy Overview

16.2.7.5.1. Marketing Strategy

16.2.7.5.2. Product Strategy

16.2.7.5.3. Route of Administration Strategy

16.2.8. Bayer AG

16.2.8.1. Overview

16.2.8.2. Product Portfolio

16.2.8.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.8.4. Sales Footprint

16.2.8.5. Strategy Overview

16.2.8.5.1. Marketing Strategy

16.2.8.5.2. Product Strategy

16.2.8.5.3. Route of Administration Strategy

16.2.9. VetStem Biopharma

16.2.9.1. Overview

16.2.9.2. Product Portfolio

16.2.9.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.9.4. Sales Footprint

16.2.9.5. Strategy Overview

16.2.9.5.1. Marketing Strategy

16.2.9.5.2. Product Strategy

16.2.9.5.3. Route of Administration Strategy

16.2.10. Dechra Pharmaceuticals PLC

16.2.10.1. Overview

16.2.10.2. Product Portfolio

16.2.10.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.10.4. Sales Footprint

16.2.10.5. Strategy Overview

16.2.10.5.1. Marketing Strategy

16.2.10.5.2. Product Strategy

16.2.10.5.3. Route of Administration Strategy

17. Assumptions and Acronyms Used

18. Research Methodology




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様